Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
Colorectal cancer (CRC) is the third most common malignancy in the world, with 22% of patients presenting with metastatic disease and a further 50% destined to develop metastasis. Molecular imaging uses antigen-specific ligands conjugated to radionuclides to detect and characterise primary cancer an...
Main Authors: | Tahleesa J. Cuda, Yaowu He, Thomas Kryza, Tashbib Khan, Brian W. Tse, Kamil A. Sokolowski, Cheng Liu, Nicholas Lyons, Madeline Gough, Cameron E. Snell, David K. Wyld, Stephen Rose, Andrew D. Riddell, Andrew R. L. Stevenson, Paul A. Thomas, David A. Clark, Simon Puttick, John D. Hooper |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2021-01-01
|
Series: | Contrast Media & Molecular Imaging |
Online Access: | http://dx.doi.org/10.1155/2021/3153278 |
Similar Items
-
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma
by: Tashbib Khan, et al.
Published: (2020-04-01) -
Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation
by: Tashbib Khan, et al.
Published: (2020-10-01) -
PLAU activates CDCP1 to promote NSCLC metastasis
by: Yi-Xuan Ke, et al.
Published: (2018) -
PLAU Promotes Cancer Cell Metastasis By Activating CDCP1
by: Hsin-Hsien Lin, et al.
Published: (2019) -
The cancer cell biology of the integral membrane protein CUB domain containing protein 1(CDCP1)
by: Orchard-Webb, David
Published: (2011)